MedTrace Logo

Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas

NCT03897673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2025-07-15

No results posted yet for this study

Summary

Daily iron (ferrous sulfate, 2 mg/kg/day) or placebo syrup for first four months (112 days) of the 12-month (336-day) study. Children in the immediate iron group will receive iron syrup for the first three months (84 days) and placebo syrup for the fourth month. Children in the delayed iron group will receive placebo syrup for the first month (28 days) and iron syrup for the second, third, and fourth months.

Conditions

Interventions

DIETARY_SUPPLEMENT

Early Iron

iron syrup for the first three months (84 days) and placebo syrup for the fourth month

DIETARY_SUPPLEMENT

Delayed Iron

placebo syrup for the first month (28 days) and iron syrup for the second, third, and fourth months

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
48 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2025-01-15
Completion
2025-01-15

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03897673 on ClinicalTrials.gov